Our technology

Delivering tomorrow’s technology today


Synvichor’s world-first gene expression technology harnesses the power of the immune system, along with automated PCR to set a new medical standard in differentiating between joint infection and inflammation.


Current culture is still reliant on the work of Koch, Hesse and Pasteur from the 1860’s. Typical wait times for results are slow and inconclusive more than 80% of the time.


Synvichor introduces novel genomic host response-based diagnostics.

Synvichor combines proprietary biomarkers with established PCR testing techniques to translate the signalling that occurs when patients suffer joint pain.


Synvichor’s unique interpretive algorithm rapidly differentiates between infectious and non-infectious joint inflammation with up to 95%+ precision.*

*For Research Use only. Not for use in diagnostic procedures.
Tech Synvichor Logo

Synvichor is a world-first in orthopaedics

Learn more

Contact us

Get in touch to find out how Synvichor can help you, your patients and your hospital.

Contact us

Be the first to know more as news breaks